BioRem Price To Sales vs. Operating Margin
| BRM Stock | CAD 3.07 0.09 2.85% |
BioRem Price To Sales Ratio |
|
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.34 | 0.279 |
|
|
For BioRem profitability analysis, we use financial ratios and fundamental drivers that measure the ability of BioRem to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well BioRem Inc utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between BioRem's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of BioRem Inc over time as well as its relative position and ranking within its peers.
BioRem |
BioRem Inc Operating Margin vs. Price To Sales Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining BioRem's current stock value. Our valuation model uses many indicators to compare BioRem value to that of its competitors to determine the firm's financial worth. BioRem Inc is number one stock in price to sales category among its peers. It also is number one stock in operating margin category among its peers reporting about 0.04 of Operating Margin per Price To Sales. The ratio of Price To Sales to Operating Margin for BioRem Inc is roughly 22.96 . At this time, BioRem's Price To Sales Ratio is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BioRem's earnings, one of the primary drivers of an investment's value.BioRem Operating Margin vs. Price To Sales
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
BioRem |
| = | 1.61 X |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
BioRem |
| = | 0.07 % |
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
BioRem Operating Margin Comparison
BioRem is currently under evaluation in operating margin category among its peers.
BioRem Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in BioRem, profitability is also one of the essential criteria for including it into their portfolios because, without profit, BioRem will eventually generate negative long term returns. The profitability progress is the general direction of BioRem's change in net profit over the period of time. It can combine multiple indicators of BioRem, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 1.3 M | 653.8 K | |
| Operating Income | 3.1 M | 3.2 M | |
| Income Before Tax | 2.8 M | 2.9 M | |
| Total Other Income Expense Net | -297 K | -282.1 K | |
| Net Income | 2.2 M | 2.3 M | |
| Income Tax Expense | 609.7 K | 640.2 K | |
| Net Income From Continuing Ops | 2.2 M | 1.3 M | |
| Net Income Applicable To Common Shares | 1.5 M | 1.2 M | |
| Net Interest Income | -273.4 K | -259.8 K | |
| Change To Netincome | 396.8 K | 416.7 K | |
| Net Income Per Share | 0.14 | 0.13 | |
| Income Quality | 0.22 | 0.17 | |
| Net Income Per E B T | 0.78 | 1.14 |
BioRem Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on BioRem. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of BioRem position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the BioRem's important profitability drivers and their relationship over time.
Use BioRem in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BioRem position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioRem will appreciate offsetting losses from the drop in the long position's value.BioRem Pair Trading
BioRem Inc Pair Trading Analysis
The ability to find closely correlated positions to BioRem could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BioRem when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BioRem - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BioRem Inc to buy it.
The correlation of BioRem is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BioRem moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BioRem Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BioRem can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your BioRem position
In addition to having BioRem in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Services Thematic Idea Now
Services
Companies involved in delivering services to business or consumers across different industries and sectors. The Services theme has 30 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Services Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for BioRem Stock Analysis
When running BioRem's price analysis, check to measure BioRem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRem is operating at the current time. Most of BioRem's value examination focuses on studying past and present price action to predict the probability of BioRem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRem's price. Additionally, you may evaluate how the addition of BioRem to your portfolios can decrease your overall portfolio volatility.